Annals of Oncology, 1569-8041

Journal

More filtering options
  1. Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer

    K. E. Aaltonen, Graffman, C., Larsson, A. M. & L. Rydén, 2015, In : Annals of Oncology. 26, Suppl. 3, p. iii15

    Research output: Contribution to journalArticle

  2. Guidance on the use of bisphosphonates in solid tumours: recommendations of an international expert panel

    Aapro, M., Abrahamsson, P-A., Body, J. J., Coleman, R. E., Colomer, R., Costa, L., Crinò, L., Dirix, L., Gnant, M., Gralow, J., Hadji, P., Hortobagyi, G. N., Jonat, W., Lipton, A., Monnier, A., Paterson, A. H. G., Rizzoli, R., Saad, F. & Thürlimann, B., 2008, In : Annals of Oncology. 19, 3, p. 420-432

    Research output: Contribution to journalArticle

  3. The role of AIB1 and PAX2 in primary breast cancer: validation of AIB1 as a negative prognostic factor.

    Alkner, S., Bendahl, P., Grabau, D., Per Malmström, Mårten Fernö & Lisa Rydén, 2013, In : Annals of Oncology. 24, 5, p. 1244-1252

    Research output: Contribution to journalArticle

  4. AIB1 is a predictive factor for tamoxifen response in premenopausal women.

    Alkner, S., Pär-Ola Bendahl, Grabau, D., Lövgren, K., Stål, O., Lisa Rydén & Mårten Fernö, 2010, In : Annals of Oncology. 21, p. 238-244

    Research output: Contribution to journalArticle

  5. Transformed diffuse large B cell lymphomas differ from follicular lymphomas in both gene and protein expression

    Ulrika Andreasson, Michael Dictor, Mats Jerkeman, Rosenquist, R., Carl Borrebaeck & Sara Ek, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 111-iv 111

    Research output: Contribution to journalPublished meeting abstract

  6. Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe

    Barkholt, L., Bregni, M., Remberger, M., Blaise, D., Peccatori, J., Massenkeil, G., Pedrazzoli, P., Zambelli, A., Bay, J. -O., Francois, S., Martino, R., Bengala, C., Brune, M., Lenhoff, S., Porcellini, A., Falda, M., Siena, S., Demirer, T., Niederwieser, D. & Ringden, O., 2006, In : Annals of Oncology. 17, 7, p. 1134-1140

    Research output: Contribution to journalArticle

  7. The genomic grade index predicts postoperative clinical outcome in patients with soft-tissue sarcoma

    Bertucci, F., De Nonneville, A., Finetti, P., Perrot, D., M. Nilbert, Italiano, A., Le Cesne, A., Skubitz, K. M., Blay, J. Y. & Birnbaum, D., 2018 Feb 1, In : Annals of Oncology. 29, 2, p. 459-465

    Research output: Contribution to journalArticle

  8. Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer

    Beyer, J., Albers, P., Altena, R., Aparicio, J., Bokemeyer, C., Busch, J., Cathomas, R., Cavallin-Ståhl, E., Clarke, N. W., Classen, J., Cohn-Cedermark, G., Dahl, A. A., Daugaard, G., De Giorgi, U., De Santis, M., De Wit, M., De Wit, R., Dieckmann, K. P., Fenner, M., Fizazi, K. & 39 others, Flechon, A., Fossa, S. D., Germa Lluch, J. R., Gietema, J. A., Gillessen, S., Aleksander Giwercman, Hartmann, J. T., Heidenreich, A., Hentrich, M., Honecker, F., Horwich, A., Huddart, R. A., Kliesch, S., Kollmannsberger, C., Krege, S., Laguna, M. P., Looijenga, L. H. J., Lorch, A., Lotz, J. P., Mayer, F., Necchi, A., Nicolai, N., Nuver, J., Oechsle, K., Oldenburg, J., Oosterhuis, J. W., Powles, T., Rajpert-De Meyts, E., Rick, O., Rosti, G., Salvioni, R., Schrader, M., Schweyer, S., Sedlmayer, F., Sohaib, A., Souchon, R., Tandstad, T., Winter, C. & Wittekind, C., 2013, In : Annals of Oncology. 24, 4, p. 878-888

    Research output: Contribution to journalReview article

  9. Central nervous system occurrence in elderly patients with aggressive lymphoma and a long-term follow-up

    Bjoerkholm, M., Hagberg, H., Holte, H., Kvaloy, S., Teerenhovi, L., Anderson, H., Cavallin-Ståhl, E., Myhre, J., Pertovaara, H., Oest, A., Nilsson, B. & Oesby, E., 2007, In : Annals of Oncology. 18, 6, p. 1085-1089

    Research output: Contribution to journalArticle

  10. Characterisation Of The Hepatic Safety Profile Of Trabectedin: Pooled Analysis Of 19 Phase II Clinical Trials (CTS) In 1132 Patients With Solid Tumours

    Blay, J., Le Cesne, A., Judson, I., Schoffski, P., Sessa, C., Paz-Ares, L., Thomas Högberg, Zintl, P., Parekh, T. V. & Demetri, G. D., 2010, In : Annals of Oncology. 21, Suppl. 8, p. 177-178

    Research output: Contribution to journalPublished meeting abstract

  11. Self-selection in sigmoidoscopy screening: A nine-year follow-up study

    Blom, J., Yin, L., Liden, A., Dolk, A., Bengt Jeppsson, Pahlman, L., Holmberg, L. & Nyren, O., 2008, In : Annals of Oncology. 19, Suppl. 6, p. 101-102

    Research output: Contribution to journalPublished meeting abstract

  12. Cancer mortality in cohorts of workers in the European rubber manufacturing industry first employed since 1975.

    Boniol, M., Koechlin, A., Świątkowska, B., Sorahan, T., Wellmann, J., Taeger, D., Jakobsson, K., Pira, E., Boffetta, P., La Vecchia, C., Pizot, C. & Boyle, P., 2016, In : Annals of Oncology. 27, 5, p. 933-941

    Research output: Contribution to journalArticle

  13. Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial

    Bonnefoi, H., Litiere, S., Piccart, M., MacGrogan, G., Fumoleau, P., Brain, E., Petit, T., Rouanet, P., Jassem, J., Moldovan, C., Bodmer, A., Zaman, K., Cufer, T., Campone, M., Luporsi, E., Per Malmström, Werutsky, G., Bogaerts, J., Bergh, J. & Cameron, D. A., 2014, In : Annals of Oncology. 25, 6, p. 1128-1136

    Research output: Contribution to journalArticle

  14. Burkitt's lymphoma: Comparison of 2 nationwide population-based lymphoma registries

    Brown, P. D., Samuelsson, V., d'Amore, F., Lindh, J., Hagberg, H., Nilsson, G., Bernell, P., Pedersen, L. M. & Mats Jerkeman, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 131-iv 131

    Research output: Contribution to journalPublished meeting abstract

  15. Measuring cancer prevalence in Europe: the EUROPREVAL project

    Capocaccia, R., Colonna, M., Corazziari, I., De Angelis, R., Francisci, S., Micheli, A., Mugno, E., EUROPREVAL Working Group:, T., Möller, T., Anderson, H. & al, E., 2002, In : Annals of Oncology. 13, 6, p. 831-839

    Research output: Contribution to journalArticle

  16. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Cardoso, F., Kyriakides, S., Ohno, S., Penault-Llorca, F., Poortmans, P., Rubio, I. T., S. Zackrisson & Senkus, E., 2019, In : Annals of Oncology. 30, 8, p. 1194-1220 27 p.

    Research output: Contribution to journalArticle

  17. Bone sarcomas: ESMO-PaedCan-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Casali, P. G., Bielack, S., Abecassis, N., Aro, H. T., Bauer, S., Biagini, R., Bonvalot, S., Boukovinas, I., Bovee, J. V. M. G., Brennan, B., Brodowicz, T., Broto, J. M., Brugières, L., Buonadonna, A., De Álava, E., Dei Tos, A. P., Del Muro, X. G., Dileo, P., Dhooge, C., Eriksson, M. & 32 others, Fagioli, F., Fedenko, A., Ferraresi, V., Ferrari, A., Ferrari, S., Frezza, A. M., Gaspar, N., Gasperoni, S., Gelderblom, H., Gil, T., Grignani, G., Gronchi, A., Haas, R. L., Hassan, B., Hecker-Nolting, S., Hohenberger, P., Issels, R., Joensuu, H., Jones, R. L., Judson, I., Jutte, P., Kaal, S., Kager, L., Kasper, B., Kopeckova, K., Krákorová, D. A., Ladenstein, R., Le Cesne, A., Lugowska, I., Merimsky, O., ESMO Guidelines Committee & PaedCan, 2018, In : Annals of Oncology. 29, p. iv79-iv95

    Research output: Contribution to journalArticle

  18. Gastrointestinal stromal tumours: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Casali, P. G. & et al., 2018 Oct 1, In : Annals of Oncology. 29, p. iv68-iv78

    Research output: Contribution to journalArticle

  19. Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up

    Mikael Eriksson & The ESMO/European Sarcoma Network Working Group, 2014, In : Annals of Oncology. 25, p. iii113-iii123

    Research output: Contribution to journalArticle

  20. Neuroendocrine pathogenesis in adenocarcinoma of the prostate

    Jens Ceder & Abrahamsson, P-A., 2001, In : Annals of Oncology. 12, Suppl. 2, p. S145-S152

    Research output: Contribution to journalArticle

  21. The prostate cancer registry: Patient characteristics, treatments and preliminary outcomes from a large observational study of metastatic castration-resistant prostate cancer (mCRPC)

    Chowdhury, S., Birtle, A. J., A. Bjartell, Costa, L. A. M., Feyerabend, S., Galli, L., Kalinka-Warzocha, E., Kramer, G., Rey, J. P. M., Lumen, N., Matveev, V. B., Paiss, T., Spaeth, D., Antoni, L., Klumper, E., Wapenaar, R. & Lee, E., 2016, In : Annals of Oncology. 27, Suppl. 6, p. vi253

    Research output: Contribution to journalArticle

  22. Cytokine gene polymorphisms and the risk of adenocarcinoma of the stomach in the European prospective investigation into cancer and nutrition (EPIC-EURGAST)

    Crusius, J. B. A., Canzian, F., Capella, G., Pena, A. S., Pera, G., Sala, N., Agudo, A., Rico, F., Del Giudice, G., Palli, D., Plebani, M., Boeing, H., Bueno-de-Mesquita, H. B., Carneiro, F., Pala, V., Save, V. E., Vineis, P., Tumino, R., Panico, S., Berglund, G. & 27 others, Manjer, J., Stenling, R., Hallmans, G., Martinez, C., Dorronsoro, M., Barricarte, A., Navarro, C., Quiros, J. R., Allen, N., Key, T. J., Binghan, S., Caldas, C., Linseisen, J., Kaaks, R., Overvad, K., Tjonneland, A., Buechner, F. C., Peeters, P. H. M., Numans, M. E., Clavel-Chapelon, F., Trichopoulou, A., Lund, E., Jenab, M., Rinaldi, S., Ferrari, P., Riboli, E. & Gonzalez, C. A., 2008, In : Annals of Oncology. 19, 11, p. 1894-1902

    Research output: Contribution to journalArticle

  23. Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma

    Michael Dictor, Sara Ek, Mats Jerkeman, Karin Jirström & Carl Borrebaeck, 2008, In : Annals of Oncology. 19, Suppl. 4, p. iv 172-iv 173

    Research output: Contribution to journalPublished meeting abstract

  24. DEVELOPMENT OF IMMUNOHISTOCHEMICAL SURROGATES FOR PREDICTION OF BREAST CANCER PATIENT OUTCOME VIA HIGH-THROUGHPUT ANTIBODY GENERATION AND APPLICATION OF TISSUE MICROARRAY TECHNOLOGY: AN INITIAL REPORT

    Dolan, R. T., Brennan, D. J., Rexhepaj, E., Kelly, C. M., Penny, S., Karin Jirström, Ponten, F., Uhlen, M. & Gallagher, W. M., 2009, In : Annals of Oncology. 20, Suppl 2, p. 54-54

    Research output: Contribution to journalPublished meeting abstract

  25. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Dreyling, M., Campo, E., Hermine, O., M. Jerkeman, Le Gouill, S., Rule, S., Shpilberg, O., Walewski, J., Ladetto, M. & on behalf of the ESMO Guidelines Committee, 2017, In : Annals of Oncology. 28, p. iv62-iv71

    Research output: Contribution to journalArticle

  26. a multicentre, phase ii study of cp-4055 in combination with sorafenib in patients with metastatic malignant melanoma

    Dueland, S., Aamdal, S., Nyakas, M., Lundgren, L., Wagenius, G., Ljuslinder, I., Stierner, U., Gaullier, J., Nilsson, B. I. & Rasch, W., 2008, In : Annals of Oncology. 19, p. 245-246

    Research output: Contribution to journalPublished meeting abstract

  27. Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: The RASTEN trial

    Ek, L., E. Gezelius, Bergman, B., P. O. Bendahl, Anderson, H., Sundberg, J., Wallberg, M., Falkmer, U., Verma, S., M. Belting & Swedish Lung Cancer Study Group (SLUSG), 2018 Feb 1, In : Annals of Oncology. 29, 2, p. 398-404

    Research output: Contribution to journalArticle

  28. Treatment (Tx) patterns and overall survival (OS) in patients (pts) with NSCLC in Sweden: A SCAN-LEAF study analysis from the I-O Optimise initiative

    Ekman, S., Sørensen, J. B., Brustugun, O. T., Horvat, P., Patel, D., Rosenlund, M., Mette Kejs, A., Juarez-Garcia, A., Daumont, M., Lacoin, L., Penrod, J. R., O'Donnell, J. C. & M. Planck, 2019 Apr, In : Annals of Oncology. 30, Suppl 2, p. ii17 1 p.

    Research output: Contribution to journalPublished meeting abstract

  29. 37p * androgen receptor expression in a population-based prospective breast cancer cohort.

    Karin Elebro, Signe Borgquist, Simonsson, M., Markkula, A., Rose, C., Christian Ingvar & Helena Jernström, 2014, In : Annals of Oncology. 25 Suppl 1, May, p. i13

    Research output: Contribution to journalPublished meeting abstract

  30. Acupuncture compared with placebo acupuncture in radiotherapy-induced nausea-a randomized controlled study

    Enblom, A., Anna Johnsson, Hammar, M., Onelov, E., Steineck, G. & Borjeson, S., 2012, In : Annals of Oncology. 23, 5, p. 1353-1361

    Research output: Contribution to journalArticle

  31. Hodgkin lymphoma after autoimmune diseases by age at diagnosis and histological subtype

    Fallah, M., Liu, X., Jianguang Ji, Asta Försti, Kristina Sundquist & Kari Hemminki, 2014, In : Annals of Oncology. 25, 7, p. 1397-1404

    Research output: Contribution to journalArticle

  32. Consumption of fish and meats and risk of hepatocellular carcinoma: the European Prospective Investigation into Cancer and Nutrition (EPIC)

    Fedirko, V., Trichopolou, A., Bamia, C., Duarte-Salles, T., Trepo, E., Aleksandrova, K., Noethlings, U., Lukanova, A., Lagiou, P., Boffetta, P., Trichopoulos, D., Katzke, V. A., Overvad, K., Tjonneland, A., Hansen, L., Boutron-Ruault, M. C., Fagherazzi, G., Bastide, N., Panico, S., Grioni, S. & 24 others, Vineis, P., Palli, D., Tumino, R., Bueno-de-Mesquita, H. B., Peeters, P. H., Skeie, G., Engeset, D., Parr, C. L., Jakszyn, P., Sanchez, M. J., Barricarte, A., Amiano, P., Chirlaque, M., Quiros, J. R., Sund, M., Werner, M., Emily Sonestedt, Ulrika Ericson, Key, T. J., Khaw, K. T., Ferrari, P., Romieu, I., Riboli, E. & Jenab, M., 2013, In : Annals of Oncology. 24, 8, p. 2166-2173

    Research output: Contribution to journalArticle

  33. Nonmetastatic Ewing family tumors: high-dose chemotherapy with stem cell rescue in poor responder patients. Results of the Italian Sarcoma Group/Scandinavian Sarcoma Group III protocol

    Ferrari, S., Hall, K. S., Luksch, R., Tienghi, A., Thomas Wiebe, Fagioli, F., Thor Alvegård, del Prever, A. B., Tamburini, A., Alberghini, M., Gandola, L., Mercuri, M., Capanna, R., Mapelli, S., Prete, A., Carli, M., Picci, P., Barbieri, E., Bacci, G. & Smeland, S., 2011, In : Annals of Oncology. 22, 5, p. 1221-1227

    Research output: Contribution to journalArticle

  34. Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

    Ferreri, AJM., Campo, E., Arnbrosetti, A., Ilariucci, F., Seymour, JF., Willemze, R., Arrigoni, G., Rossi, G., Lopez-Guillermo, A., Berti, E., Eriksson, M., Federico, M., Cortelazzo, S., Govi, S., Frungillo, N., Dell'Oro, S., Lestani, M., Asioli, S., Pedrinis, E., Ungari, M. & 7 others, Motta, T., Rossi, R., Artusi, T., Iuzzolino, P., Zucca, E., Cavalli, F. & Ponzoni, M., 2004, In : Annals of Oncology. 15, 8, p. 1215-1221

    Research output: Contribution to journalArticle

  35. Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial. Measuring what matters-patient-centered end points in trials of maintenance therapy

    Friedlander, M., Rau, J., Lee, C. K., Meier, W., Lesoin, A., Kim, J. W., Poveda, A., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M. T., Debruyne, P., Bologna, A., Malander, S., Monk, B. J., Petru, E., Calvert, P., Herzog, T. J., Barrett, C. & 1 others, du Bois, A., 2018 Mar 1, In : Annals of Oncology. 29, 3, p. 737-743 7 p., mdx821.

    Research output: Contribution to journalArticle

  36. Colon cancer prevalence and estimation of differing care needs of colon cancer patients

    Gatta, G., Capocaccia, R., Berrino, F., Ruzza, M. R., Contiero, P., Möller, T. & EUROPREVAL Working Group, A. T., 2004, In : Annals of Oncology. 15, 7, p. 1136-1142

    Research output: Contribution to journalArticle

  37. A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer

    Glimelius, B., Sorbye, H., Balteskard, L., Bystrom, P., Pfeiffer, P., Tveit, K., Heikkila, R., Keldsen, N., Albertsson, M., Starkhammar, H., Garmo, H. & Berglund, A., 2008, In : Annals of Oncology. 19, 5, p. 909-914

    Research output: Contribution to journalArticle

  38. Mutational mechanisms of amplifications revealed by analysis of clustered rearrangements in breast cancers

    Glodzik, D., Purdie, C. A., Rye, I. H., Simpson, P. T., Johan Staaf, Span, P. N., Russnes, H. & Nik-Zainal, S., 2018 Sep 15, In : Annals of Oncology. 30252041.

    Research output: Contribution to journalArticle

  39. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project

    Gonzalez, C. A., Megraud, F., Buissonniere, A., Lujan Barroso, L., Agudo, A., Duell, E. J., Boutron-Ruault, M. C., Clavel-Chapelon, F., Palli, D., Krogh, V., Mattiello, A., Tumino, R., Sacerdote, C., Quiros, J. R., Sanchez-Cantalejo, E., Navarro, C., Barricarte, A., Dorronsoro, M., Khaw, K. -T., Wareham, N. & 31 others, Allen, N. E., Tsilidis, K. K., Bueno-de-Mesquita, H. B., Jeurnink, S. M., Numans, M. E., Peeters, P. H. M., Lagiou, P., Valanou, E., Trichopoulou, A., Kaaks, R., Lukanova-McGregor, A., Bergman, M. M., Boeing, H., Jonas Manjer, Lindkvist, B., Stenling, R., Hallmans, G., Mortensen, L. M., Overvad, K., Olsen, A., Tjonneland, A., Bakken, K., Dumeaux, V., Lund, E., Jenab, M., Romieu, I., Michaud, D., Mouw, T., Carneiro, F., Fenge, C. & Riboli, E., 2012, In : Annals of Oncology. 23, 5, p. 1320-1324

    Research output: Contribution to journalArticle

  40. A randomized study of KRAS-guided maintenance therapy with bevacizumab, erlotinib or metronomic capecitabine after first line induction treatment of metastatic colorectal cancer: the Nordic ACT2 trial

    Helga Hagman, Frödin, J-E., Berglund, Å., Sundberg, J., Vestermark, L., Albertsson, M., Fernebro, E. & Anders Johnsson, 2016 Jan, In : Annals of Oncology. 27, 1, p. 140-147

    Research output: Contribution to journalArticle

  41. Survival in cancer of unknown primary site: population-based analysis by site and histology

    Kari Hemminki, Bevier, M., Hemminki, A. & Jan Sundquist, 2012, In : Annals of Oncology. 23, 7, p. 1854-1863

    Research output: Contribution to journalArticle

Previous 1 2 3 Next